Georg Tschank

800 citations

19 papers · 589 indexed · h-index 13

Impact in

Cancer Research
- Cancer, Hypoxia, and Metabolism
Endocrinology, Diabetes and Metabolism top 10%
- Diabetes Management and Research
- Growth Hormone and Insulin-like Growth Factors
- Diabetes Treatment and Management

Papers in

Biochemistry 2
Cancer Research 4
- Cancer, Hypoxia, and Metabolism 4

Co-authors: Volkmar Günzler Norbert Tennagels Hartmut M. Hanauske‐Abel Karl‐Heinz Baringhaus E. Baader R. Kurrle Mark Sommerfeld Günter Müller
Journals: Biochemical Journal (4 papers)Archives of Biochemistry and Biophysics (2 papers)PLoS ONE (2 papers)The Journal of Cell Biology (1 paper)Journal of Molecular Endocrinology (1 paper)
Partner nations: Germany United States Finland

In The Last Decade

Georg Tschank

19 papers receiving 567 citations

Peers

Countries citing papers authored by Georg Tschank

Since Specialization

Citations

This map shows the geographic impact of Georg Tschank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg Tschank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg Tschank more than expected).

Fields of papers citing papers by Georg Tschank

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georg Tschank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg Tschank. The network helps show where Georg Tschank may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Georg Tschank, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Georg Tschank Line = papers co-authored together Georg Tschank links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	1,1-Dioxo-5,6-dihydro-[4,1,2]oxathiazines, a novel class of 11ß-HSD1 inhibitors for the treatment of diabetes Bioorganic & Medicinal Chemistry Letters ·Thomas Böhme, Christian K. Engel, Géraldine Farjot, Stefan Güssregen, Torsten Haack, Georg Tschank, Kurt Ritter	2013	19
2	Effect of Insulin Analogues on Insulin/IGF1 Hybrid Receptors: Increased Activation by Glargine but Not by Its Metabolites M1 and M2 PLoS ONE ·Cécile Pierre‐Eugène, Patrick Pagésy, Jeanne Martins Mecenas, Marion Neuillé, Georg Tschank, Norbert Tennagels, Christiane S. Hampe, Tarik Issad	2012	55
3	In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites PLoS ONE ·Mark Sommerfeld, Günter Müller, Georg Tschank, Gerhard Seipke, L. V. Cherlіnka, R. Kurrle, Norbert Tennagels	2010	111
4	Gene expression profiling in skeletal muscle of Zucker diabetic fatty rats: implications for a role of stearoyl-CoA desaturase 1 in insulin resistance Diabetologia ·张榛, K. W. Salter, Norbert Tennagels, Georg Tschank, Andreas W. Herling, Risky Sintia Sari, Martin Gerl, W. Emboden, Sonia Horst, Ботир Намозович Кузиев	2005	46
5	Differential hepatic gene expression in a polygenic mouse model with insulin resistance and hyperglycemia: evidence for a combined transcriptional dysregulation of gluconeogenesis and fatty acid synthesis Journal of Molecular Endocrinology ·Walter Becker, Reinhart Kluge, Theodore R. Kantner, 野崎宏伸, Ботир Намозович Кузиев, Georg Tschank, Leona Plum, Indalecio Cruz Ferreiro, Hans‐Georg Joost	2004	28
6	Selective inhibition of hepatic collagen accumulation in experimental liver fibrosis in rats by a new prolyl 4-hydroxylase inhibitor Hepatology ·Martin Bickel, Karl‐Heinz Baringhaus, Martin Gerl, Volkmar Günzler, J Kanta, Ludwig Schmidts, Michael Stapf, Georg Tschank, د وائل السید العبد خلیفة, Werner Ulrich	1998	58
7	Structural requirements for the utilization of ascorbate analogues in the prolyl 4-hydroxylase reaction Biochemical Journal ·Georg Tschank, Naura Afifah Mujoko, Karl‐Heinz Baringhaus, Franz Dallacker, Kari I. Kivirikko, Volkmar Günzler	1994	21
8	Inhibition of prolyl 4-hydroxylase by oxalyl amino acid derivatives in vitro, in isolated microsomes and in embryonic chicken tissues Biochemical Journal ·E. Baader, Georg Tschank, Karl‐Heinz Baringhaus, Jorge E Gallego, Volkmar Günzler	1994	58
9	Inhibition of prolyl hydroxylation and procollagen processing in chick-embryo calvaria by a derivative of pyridine-2,4-dicarboxylate. Characterization of the diethyl ester as a proinhibitor Biochemical Journal ·Georg Tschank, K. Chatopadhyay, K. Engelbart, Julia Mohr, E. Baader, Volkmar Günzler, Hartmut M. Hanauske‐Abel	1991	31
10	Isolation and characterization of a 60-70-kD plasma membrane glycoprotein involved in the contact-dependent inhibition of growth. The Journal of Cell Biology ·Raimund Wieser, Xian Shan Liu, Georg Tschank, Helmut Thomas, H. P. Dienes, Franz Oesch	1990	45
11	The effectiveness of inhibitors of soluble prolyl hydroxylase against the enzyme in the cisternae of isolated bone microsomes Archives of Biochemistry and Biophysics ·Georg Tschank, Hartmut M. Hanauske‐Abel, Beverly Peterkofsky	1988	11
12	Pyridinedicarboxylates, the first mechanism-derived inhibitors for prolyl 4-hydroxylase, selectively suppress cellular hydroxyprolyl biosynthesis. Decrease in interstitial collagen and Clq secretion in cell culture Biochemical Journal ·Georg Tschank, Michael Raghunath, Volkmar Günzler, Hartmut M. Hanauske‐Abel	1987	38
13	Iron-dependent uptake of ascorbate into isolated microsomes Archives of Biochemistry and Biophysics ·Beverly Peterkofsky, Georg Tschank, Christina Luedke	1987	13
14	Pyrroloquinoline quinone and molecules mimicking its functional domains Modulators of connective tissue formation? FEBS Letters ·Hartmut M. Hanauske‐Abel, Georg Tschank, Volkmar Günzler, E. Baader, Paul M. Gallop	1987	11
15	Butyrate-synchronized cloned T cells retain their dependence on interleukin-2 for growth induction Experimental Cell Research ·Ulrich Moebius, Volkmar Günzler, Hartmut M. Hanauske‐Abel, حنان ‏ تلولي, Erwin Rüde, Georg Tschank	1987	6
16	Immunological effects of thalidomide. Inactivity of the drug and several of its hydrolysis products in mononucleocyte proliferation tests. PubMed ·Volkmar Günzler, Hartmut M. Hanauske‐Abel, Georg Tschank, H. Schulte-Wissermann	1986	11
17	Alzheimer's Disease: A Cerebral AmyloidosisA Cooperative Study to Correlate Clinical, Biochemical and Pathologic-anatomical Findings Pharmacopsychiatry ·J. Böhl, S Störkel, Eva Schulze, Georg Tschank, Anisah Novi Karunia, M. Garmyn, SHELL OIL CO DENVER CO, Mekuria Bulie, D G Brocks	1986	2
18	Effects of Hydrazyl Group Containing Drugs on Leucocyte Functions: An Immunoregulatory Model for the Hydralazine-Induced Lupus-Like Syndrome PubMed ·R. E. Schopf, Hartmut M. Hanauske‐Abel, Georg Tschank, H. Schulte-Wissermann, Volkmar Günzler	1985	9
19	Contracting striated muscle fibres differentiated from primary rat pituitary cultures Cell and Tissue Research ·Gerd Brunner, Georg Tschank	1982	16

About Georg Tschank

Georg Tschank is a scholar working on Biochemistry, Cancer Research, Cell Biology, Endocrinology, Diabetes and Metabolism and Physiology, having authored 19 papers that have together received 589 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Aldose Reductase and Taurine (3 papers), Biochemical effects in animals (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers), Metabolism, Diabetes, and Cancer (3 papers), Muscle metabolism and nutrition (2 papers), Adipose Tissue and Metabolism (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Cancer Research (130 citations), Endocrinology, Diabetes and Metabolism (142 citations), Biochemistry (52 citations), Molecular Biology (349 citations) and Hepatology (36 citations). Georg Tschank has collaborated with scholars based in Germany, United States and Finland. Frequent co-authors include Volkmar Günzler, Norbert Tennagels, Hartmut M. Hanauske‐Abel, Karl‐Heinz Baringhaus, E. Baader, R. Kurrle, Mark Sommerfeld, Günter Müller, Gerhard Seipke and Martin Gerl. Their work appears in journals such as Biochemical Journal, Archives of Biochemistry and Biophysics, PLoS ONE, The Journal of Cell Biology and Journal of Molecular Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact